Titan Pharmaceuticals, Inc. (TTNP) Social Stream
TITAN PHARMACEUTICALS INC (TTNP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TITAN PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-14 | 1 | $7 | $7 | $7 | $0.425 | 1547.06% |
| NA | 1 | $NA | $NA | $NA | $0.425 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
Over the past 129 days, TTNP's average price target has gone down $0.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
TTNP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TTNP as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, TITAN PHARMACEUTICALS INC's number of analysts covering the stock is greater than just about none of of them.
- In the context of all US stocks, TITAN PHARMACEUTICALS INC's variance in analysts' estimates is lower than almost 100% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, TITAN PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 94.44% of them.
- TITAN PHARMACEUTICALS INC's average analyst price target is greater than 11.28% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TITAN PHARMACEUTICALS INC are BCDA, LIFE, and DBVT.
View All Top Stocks by Price Target
Is TTNP a Buy, Hold or Sell? See the POWR Ratings now!